The winners of the 2021 Clinical Researcher of the Year – The Americas have been announced, find out who emerged victorious
News
Double vaccinated can still spread COVID-19 at home, says UK study
Experts say that it is vital to ensure that every member who is eligible for a vaccine has received one
EMA nod for excessive daytime sleepiness med Ozawade
Med approved for the treatment of excessive daytime sleepiness associated with obstructive sleep apnoea in adults
FDA panel OK’s Pfizer/BioNTech jab for children aged five to 11
The FDA will likely make a formal decision on the use of the vaccine in this age group in the coming days
Record 1.6 million receive COVID-19 boosters over seven days
More than 85 million vaccines have already been delivered and nine in ten adults have had their first dose
Strategic collaboration strengthens lupus clinical research in UK
There is currently no cure for lupus, and many of the existing therapies have shown varying degrees of success
New collaboration to develop next-gen diagnostic platform for early cancer detection
Partnership will see DNAe, Imperial College London and the University of Leicester collaborate on early detection of recurrent breast cancer
Priority review for Novartis CAR-T cell therapy Kymriah
Novartis is eyeing approval for Kymriah to treat adult patients with relapsed or refractory follicular lymphoma
Stallergenes Greer and Aptar Pharma to develop immunotherapy treatment device
The development of the device is being carried out by Aptar Pharma’s Digital Health group
Sturgeon urged to speed COVID booster jab rollout as vulnerable groups left waiting
Opposition leaders have emphasised that more than 100,000 people eligible for a third dose have not yet received it
MHRA licenses Ryeqo for symptoms of uterine fibroids
First oral GnRH antagonist to be licensed in Great Britain for these women
UK COVID-19 patients able to take GP prescribed medicine at home
The drug acts by inhibiting SARS-CoV-2 from replicating in the human system
NICE does not recommend tucatinib for advanced breast cancer
Tucatinib, a tyrosine kinase inhibitor, works by blocking a specific area of the HER2 gene in cancer cells
Roche launches Foundation Medicine-partnered genomic profiling kit
Product designed to allow laboratories to expand in-house oncology research
EC approves Keytruda regimen for triple-negative breast cancer
Approval covers patients with locally recurrent or metastatic TNBC
